2017 MS Highlights: The Year in Review

Article Type
Changed
Tue, 05/21/2019 - 12:13
Publications
Topics
Sections
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

Transforming the delivery of cardiovascular care: Research and innovation in the Heart & Vascular Institute

Article Type
Changed
Wed, 04/10/2019 - 11:16
Display Headline
Transforming the delivery of cardiovascular care: Research and innovation in the Heart & Vascular Institute
Selected presentations from Sones/Favaloro Scientific Program
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 84(12)
Publications
Topics
Page Number
e1-e33
Sections
Article PDF
Article PDF
Selected presentations from Sones/Favaloro Scientific Program
Selected presentations from Sones/Favaloro Scientific Program
Issue
Cleveland Clinic Journal of Medicine - 84(12)
Issue
Cleveland Clinic Journal of Medicine - 84(12)
Page Number
e1-e33
Page Number
e1-e33
Publications
Publications
Topics
Article Type
Display Headline
Transforming the delivery of cardiovascular care: Research and innovation in the Heart & Vascular Institute
Display Headline
Transforming the delivery of cardiovascular care: Research and innovation in the Heart & Vascular Institute
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2017 December;84(12 suppl 4):e1-e33
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Challenges and advances in cardiovascular disease

Article Type
Changed
Wed, 04/10/2019 - 11:07
Display Headline
Challenges and advances in cardiovascular disease

Supplement Editor:
Maan A. Fares, MD

Contents

Introduction: Challenges and advances in cardiovascular disease
Maan A. Fares

Cardiac amyloidosis: An update on diagnosis and treatment
Joseph P. Donnelly and Mazen Hanna

Management of coronary chronic total occlusion
Jaikirshan Khatri, Mouin Abdallah, and Stephen Ellis

Update on the management of venous thromboembolism
John R. Bartholomew

Cardiac implantable electronic device infection
Cameron T. Lambert and Khaldoun G. Tarakji

Lung transplant: Candidates for referral and the waiting list
Kenneth R. McCurry and Marie M. Budev

Article PDF
Issue
Cleveland Clinic Journal of Medicine - 84(12)
Publications
Topics
Page Number
1-60
Sections
Article PDF
Article PDF

Supplement Editor:
Maan A. Fares, MD

Contents

Introduction: Challenges and advances in cardiovascular disease
Maan A. Fares

Cardiac amyloidosis: An update on diagnosis and treatment
Joseph P. Donnelly and Mazen Hanna

Management of coronary chronic total occlusion
Jaikirshan Khatri, Mouin Abdallah, and Stephen Ellis

Update on the management of venous thromboembolism
John R. Bartholomew

Cardiac implantable electronic device infection
Cameron T. Lambert and Khaldoun G. Tarakji

Lung transplant: Candidates for referral and the waiting list
Kenneth R. McCurry and Marie M. Budev

Supplement Editor:
Maan A. Fares, MD

Contents

Introduction: Challenges and advances in cardiovascular disease
Maan A. Fares

Cardiac amyloidosis: An update on diagnosis and treatment
Joseph P. Donnelly and Mazen Hanna

Management of coronary chronic total occlusion
Jaikirshan Khatri, Mouin Abdallah, and Stephen Ellis

Update on the management of venous thromboembolism
John R. Bartholomew

Cardiac implantable electronic device infection
Cameron T. Lambert and Khaldoun G. Tarakji

Lung transplant: Candidates for referral and the waiting list
Kenneth R. McCurry and Marie M. Budev

Issue
Cleveland Clinic Journal of Medicine - 84(12)
Issue
Cleveland Clinic Journal of Medicine - 84(12)
Page Number
1-60
Page Number
1-60
Publications
Publications
Topics
Article Type
Display Headline
Challenges and advances in cardiovascular disease
Display Headline
Challenges and advances in cardiovascular disease
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2017 December;84(12 suppl 3):1-60
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Modern Day Laboring

Article Type
Changed
Tue, 05/05/2020 - 17:08

Click here to read the supplement

Modern Day Laboring

 

Induction of Labor for Low-Risk Women: Is 39 the New 41?

Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA 

Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care

Julian N. Robinson, MD; Sarah E. Little, MD

 

Click here to read the supplement

Sponsor
This supplement is sponsored by Ferring Pharmaceuticals Inc.
Publications
Topics
Sections
Sponsor
This supplement is sponsored by Ferring Pharmaceuticals Inc.
Sponsor
This supplement is sponsored by Ferring Pharmaceuticals Inc.

Click here to read the supplement

Modern Day Laboring

 

Induction of Labor for Low-Risk Women: Is 39 the New 41?

Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA 

Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care

Julian N. Robinson, MD; Sarah E. Little, MD

 

Click here to read the supplement

Click here to read the supplement

Modern Day Laboring

 

Induction of Labor for Low-Risk Women: Is 39 the New 41?

Rohan D’Souza, MD, MSc, MRCOG; Errol R. Norwitz, MD, PhD, MBA 

Cervical Ripening in Alternative Settings: Balancing Logistics and Patient Care

Julian N. Robinson, MD; Sarah E. Little, MD

 

Click here to read the supplement

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.

Highlights From the 7th Joint ECTRIMS‑ACTRIMS Meeting

Article Type
Changed
Tue, 05/21/2019 - 12:13
Publications
Topics
Sections
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

Pediatric Vaccines & Infectious Diseases: Fall 2017

Article Type
Changed
Tue, 07/23/2019 - 14:07
Display Headline
Pediatric Vaccines & Infectious Diseases: Fall 2017

An editorial supplement to Pediatric News.

Articles Include:

  • The perpetual challenge of emerging infections
  • Teen vaccines: Where are we now, and how can we go further?
  • Parental reasons for HPV nonvaccination are shifting
  • Make HIV testing of adolescents routine

Faculty:

Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

Publications
Topics
Sections

An editorial supplement to Pediatric News.

Articles Include:

  • The perpetual challenge of emerging infections
  • Teen vaccines: Where are we now, and how can we go further?
  • Parental reasons for HPV nonvaccination are shifting
  • Make HIV testing of adolescents routine

Faculty:

Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

An editorial supplement to Pediatric News.

Articles Include:

  • The perpetual challenge of emerging infections
  • Teen vaccines: Where are we now, and how can we go further?
  • Parental reasons for HPV nonvaccination are shifting
  • Make HIV testing of adolescents routine

Faculty:

Michael E. Pichichero, M.D.
Dr. Pichichero, a specialist in pediatric infectious diseases, is director of the Research Institute, Rochester (N.Y.) General Hospital. He is also a pediatrician at Legacy Pediatrics in Rochester. He is an ID Consult columnist for Pediatric News. Dr. Pichichero said that in the past 3 years he has received research funding from Sanofi Pasteur and Merck for investigator-initiated research for vaccine-related research, but not specifically relating to any of the vaccines and topics included in this supplement..

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

Publications
Publications
Topics
Article Type
Display Headline
Pediatric Vaccines & Infectious Diseases: Fall 2017
Display Headline
Pediatric Vaccines & Infectious Diseases: Fall 2017
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.

JFP PCEC Injectable Insulin Supplement

Article Type
Changed
Tue, 05/03/2022 - 15:22
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Sponsor
Issue
The Journal of Family Practice - 66(10)
Publications
Topics
Sections
Sponsor
Sponsor

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Issue
The Journal of Family Practice - 66(10)
Issue
The Journal of Family Practice - 66(10)
Publications
Publications
Topics
Article Type
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

Advantages of In-office Hysteroscopy in the Diagnosis of Abnormal Uterine Bleeding with Endosee

Article Type
Changed
Tue, 05/05/2020 - 17:15
Display Headline
Advantages of In-office Hysteroscopy in the Diagnosis of Abnormal Uterine Bleeding with Endosee®

Click Here to Read the Supplement.

 

Topics include:

  • The Endosee Office Procedure
  • Patient Case Studies
  • Advantages of Endosee Over Traditional Office Hysteroscopy

Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan

Click Here to Read the Supplement.

 

Sponsor
Publications
Sections
Sponsor
Sponsor

Click Here to Read the Supplement.

 

Topics include:

  • The Endosee Office Procedure
  • Patient Case Studies
  • Advantages of Endosee Over Traditional Office Hysteroscopy

Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan

Click Here to Read the Supplement.

 

Click Here to Read the Supplement.

 

Topics include:

  • The Endosee Office Procedure
  • Patient Case Studies
  • Advantages of Endosee Over Traditional Office Hysteroscopy

Dr. Ethan Goldstein, MD
Director of the Robotic
and Minimally Invasive Surgery Program
Detroit Medical Center’s Huron Valley-Sinai Hospital
Detroit, Michigan

Click Here to Read the Supplement.

 

Publications
Publications
Article Type
Display Headline
Advantages of In-office Hysteroscopy in the Diagnosis of Abnormal Uterine Bleeding with Endosee®
Display Headline
Advantages of In-office Hysteroscopy in the Diagnosis of Abnormal Uterine Bleeding with Endosee®
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.

Abstracts Presented at the 2017 AVAHO Annual Meeting (Digital Edition)

Article Type
Changed
Tue, 05/21/2019 - 12:13
Display Headline
Abstracts Presented at the 2017 AVAHO Annual Meeting
September 15-17, 2017 ► Denver, CO
Publications
Topics
Sections
September 15-17, 2017 ► Denver, CO
September 15-17, 2017 ► Denver, CO
Publications
Publications
Topics
Article Type
Display Headline
Abstracts Presented at the 2017 AVAHO Annual Meeting
Display Headline
Abstracts Presented at the 2017 AVAHO Annual Meeting
Sections
Citation Override
Fed Pract. 2017 August;34(suppl 6)
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default